Boundless Bio, Inc.BOLDNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank43
3Y CAGR+6.5%
5Y CAGR-15.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+6.5%/yr
vs -6.6%/yr prior
5Y CAGR
-15.5%/yr
Recent acceleration
Acceleration
+13.0pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.84M | -18.9% |
| 2024 | $55.27M | +29.6% |
| 2023 | $42.64M | +14.7% |
| 2022 | $37.16M | +92.8% |
| 2021 | $19.28M | -81.5% |
| 2018 | $104.37M | +37.5% |
| 2017 | $75.90M | +55.6% |
| 2016 | $48.77M | - |